UnicoCell Biomed Co., Ltd. (TPE:6794)
Taiwan
· Delayed Price · Currency is TWD 65.10
0.00 (0.00%)
May 7, 2025, 1:30 PM CST
UnicoCell Biomed Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Revenue | 31.88 | 24.59 | 14.4 | 8.18 | 3.98 | Upgrade
|
| Revenue Growth (YoY) | 29.66% | 70.79% | 76.07% | 105.35% | -74.70% | Upgrade
|
| Cost of Revenue | 11.31 | 6.69 | 6.2 | 2.35 | 1.64 | Upgrade
|
| Gross Profit | 20.57 | 17.9 | 8.2 | 5.83 | 2.34 | Upgrade
|
| Selling, General & Admin | 34.85 | 31.4 | 25.4 | 23.3 | 21.94 | Upgrade
|
| Research & Development | 88.64 | 82.78 | 74.91 | 69.87 | 91.76 | Upgrade
|
| Operating Expenses | 123.49 | 114.18 | 100.31 | 93.17 | 113.69 | Upgrade
|
| Operating Income | -102.92 | -96.28 | -92.11 | -87.34 | -111.35 | Upgrade
|
| Interest Expense | -1.47 | -1.45 | -1.26 | -0.66 | -0.94 | Upgrade
|
| Interest & Investment Income | 7.54 | 5.79 | 0.84 | 0.08 | 0.36 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.02 | 0.01 | 0.05 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 5.13 | 3.04 | 1.18 | 1.54 | 2.73 | Upgrade
|
| EBT Excluding Unusual Items | -91.7 | -88.9 | -91.3 | -86.37 | -109.21 | Upgrade
|
| Gain (Loss) on Sale of Investments | -1.79 | - | 0.1 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.41 | 4.79 | - | - | - | Upgrade
|
| Other Unusual Items | - | - | 0.05 | - | - | Upgrade
|
| Pretax Income | -93.07 | -84.11 | -91.16 | -86.37 | -109.21 | Upgrade
|
| Net Income | -93.07 | -84.11 | -91.16 | -86.37 | -109.21 | Upgrade
|
| Net Income to Common | -93.07 | -84.11 | -91.16 | -86.37 | -109.21 | Upgrade
|
| Shares Outstanding (Basic) | 57 | 54 | 41 | 38 | 36 | Upgrade
|
| Shares Outstanding (Diluted) | 57 | 54 | 41 | 38 | 36 | Upgrade
|
| Shares Change (YoY) | 6.68% | 29.61% | 10.12% | 6.10% | 17.04% | Upgrade
|
| EPS (Basic) | -1.62 | -1.56 | -2.20 | -2.29 | -3.07 | Upgrade
|
| EPS (Diluted) | -1.62 | -1.56 | -2.20 | -2.29 | -3.07 | Upgrade
|
| Free Cash Flow | -66.84 | -81.35 | -78.05 | -85.34 | -148.85 | Upgrade
|
| Free Cash Flow Per Share | -1.17 | -1.51 | -1.88 | -2.27 | -4.19 | Upgrade
|
| Gross Margin | 64.52% | 72.78% | 56.93% | 71.32% | 58.71% | Upgrade
|
| Operating Margin | -322.83% | -391.56% | -639.78% | -1068.08% | -2796.43% | Upgrade
|
| Profit Margin | -291.94% | -342.06% | -633.15% | -1056.30% | -2742.57% | Upgrade
|
| Free Cash Flow Margin | -209.66% | -330.82% | -542.15% | -1043.70% | -3737.95% | Upgrade
|
| EBITDA | -82.37 | -76.71 | -76.25 | -71.24 | -98.68 | Upgrade
|
| EBITDA Margin | -258.35% | - | - | - | - | Upgrade
|
| D&A For EBITDA | 20.56 | 19.57 | 15.86 | 16.1 | 12.67 | Upgrade
|
| EBIT | -102.92 | -96.28 | -92.11 | -87.34 | -111.35 | Upgrade
|
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.